Aligos Therapeutics Inc (ALGS)
0.801
-0.04
(-4.67%)
USD |
NASDAQ |
Apr 17, 16:00
0.801
0.00 (0.00%)
After-Hours: 20:00
Aligos Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Mirum Pharmaceuticals Inc | 64.03% |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 81.54% |
IGC Pharma Inc | 65.20% |
NovaBay Pharmaceuticals Inc | 48.70% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -108.2% |
Return on Assets | -71.64% |
Return on Invested Capital | -108.2% |
Profit Margin (Quarterly) | -1.04K% |
Operating Margin (Quarterly) | -969.7% |
Return on Net Operating Assets | -784.8% |